BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22013129)

  • 21. IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth.
    Yang R; Yao L; Shen L; Sha W; Modlin RL; Shen H; Chen ZW
    Front Immunol; 2019; 10():913. PubMed ID: 31080452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates.
    Shen L; Frencher J; Huang D; Wang W; Yang E; Chen CY; Zhang Z; Wang R; Qaqish A; Larsen MH; Shen H; Porcelli SA; Jacobs WR; Chen ZW
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6371-6378. PubMed ID: 30850538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells.
    Morita CT; Lee HK; Wang H; Li H; Mariuzza RA; Tanaka Y
    J Immunol; 2001 Jul; 167(1):36-41. PubMed ID: 11418629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multieffector-functional immune responses of HMBPP-specific Vγ2Vδ2 T cells in nonhuman primates inoculated with Listeria monocytogenes ΔactA prfA*.
    Ryan-Payseur B; Frencher J; Shen L; Chen CY; Huang D; Chen ZW
    J Immunol; 2012 Aug; 189(3):1285-93. PubMed ID: 22745375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen.
    Miyagawa F; Tanaka Y; Yamashita S; Minato N
    J Immunol; 2001 May; 166(9):5508-14. PubMed ID: 11313389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells.
    Arkko S; Zlatev HP; Mönkkönen H; Räikkönen J; Benzaïd I; Clézardin P; Mönkkönen J; Määttä JA
    Cancer Lett; 2015 Feb; 357(1):279-285. PubMed ID: 25444923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins prevent bisphosphonate-induced gamma,delta-T-cell proliferation and activation in vitro.
    Thompson K; Rogers MJ
    J Bone Miner Res; 2004 Feb; 19(2):278-88. PubMed ID: 14969398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate.
    Wesch D; Marx S; Kabelitz D
    Eur J Immunol; 1997 Apr; 27(4):952-6. PubMed ID: 9130649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells.
    Li J; Herold MJ; Kimmel B; Müller I; Rincon-Orozco B; Kunzmann V; Herrmann T
    J Immunol; 2009 Jun; 182(12):8118-24. PubMed ID: 19494338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
    Henneman L; van Cruchten AG; Kulik W; Waterham HR
    Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional profiling of gamma delta T cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands.
    Chen L; Cencioni MT; Angelini DF; Borsellino G; Battistini L; Brosnan CF
    J Immunol; 2005 May; 174(10):6144-52. PubMed ID: 15879110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.
    Benzaïd I; Mönkkönen H; Stresing V; Bonnelye E; Green J; Mönkkönen J; Touraine JL; Clézardin P
    Cancer Res; 2011 Jul; 71(13):4562-72. PubMed ID: 21646473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay of T-cell receptor and interleukin-2 signalling in Vγ2Vδ2 T-cell cytotoxicity.
    Li H; David Pauza C
    Immunology; 2011 Jan; 132(1):96-103. PubMed ID: 20738419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccination.
    Shen H; Wang Y; Chen CY; Frencher J; Huang D; Yang E; Ryan-Payseur B; Chen ZW
    Eur J Immunol; 2015 Feb; 45(2):442-51. PubMed ID: 25141829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections.
    Chen ZW
    Cell Mol Immunol; 2013 Jan; 10(1):58-64. PubMed ID: 23147720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic and antioxidant effects of a pathogen-associated prenyl pyrophosphate in Anopheles gambiae.
    Lindberg BG; Merritt EA; Rayl M; Liu C; Parmryd I; Olofsson B; Faye I
    PLoS One; 2013; 8(8):e73868. PubMed ID: 23967351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells.
    Ness-Schwickerath KJ; Jin C; Morita CT
    J Immunol; 2010 Jun; 184(12):7268-80. PubMed ID: 20483730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques.
    Ali Z; Shao L; Halliday L; Reichenberg A; Hintz M; Jomaa H; Chen ZW
    J Immunol; 2007 Dec; 179(12):8287-96. PubMed ID: 18056373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs.
    Wang H; Fang Z; Morita CT
    J Immunol; 2010 Jun; 184(11):6209-22. PubMed ID: 20483784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.
    Kato Y; Tanaka Y; Tanaka H; Yamashita S; Minato N
    J Immunol; 2003 Apr; 170(7):3608-13. PubMed ID: 12646624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.